138 related articles for article (PubMed ID: 38330765)
21. Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids.
Song H; Bucher S; Rosenberg K; Tsui M; Burhan D; Hoffman D; Cho SJ; Rangaswami A; Breese M; Leung S; Ventura MVP; Sweet-Cordero EA; Huang FW; Nijagal A; Wang B
Nat Commun; 2022 Aug; 13(1):4878. PubMed ID: 36008377
[TBL] [Abstract][Full Text] [Related]
22. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
23. Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma.
Sha YL; Liu S; Yan WW; Dong B
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31511432
[TBL] [Abstract][Full Text] [Related]
24. Relationship of β-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma.
Gupta K; Rane S; Das A; Marwaha RK; Menon P; Rao KL
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e320-8. PubMed ID: 22735888
[TBL] [Abstract][Full Text] [Related]
25. Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.
Abril-Fornaguera J; Torrens L; Andreu-Oller C; Carrillo-Reixach J; Rialdi A; Balaseviciute U; Pinyol R; Montironi C; Haber PK; Del Río-Álvarez Á; Domingo-Sàbat M; Royo L; Akers NK; Willoughby CE; Peix J; Torres-Martin M; Puigvehi M; Cairo S; Childs M; Maibach R; Alaggio R; Czauderna P; Morland B; Losic B; Mazzaferro V; Guccione E; Sia D; Armengol C; Llovet JM
Mol Cancer Ther; 2023 Apr; 22(4):485-498. PubMed ID: 36780225
[TBL] [Abstract][Full Text] [Related]
26. Fetal and neonatal hepatic tumors.
Isaacs H
J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
[TBL] [Abstract][Full Text] [Related]
27. Multidisciplinary Management of Pediatric Hepatoblastoma: A 20-Year Single-Center Experience.
Tayfun Küpesiz F; Akınel AN; Akbaş H; Sivrice Ç; Tüysüz Kintrup G; Karagüzel G; Melikoğlu M; Gelen MT; Aydınlı B; Küpesiz A; Güler E
Turk J Gastroenterol; 2022 Dec; 33(12):1069-1078. PubMed ID: 36262102
[TBL] [Abstract][Full Text] [Related]
28. Contrast-enhanced CT features of hepatoblastoma: Can we predict histopathology?
Baheti AD; Luana Stanescu A; Li N; Chapman T
Clin Imaging; 2017; 44():33-37. PubMed ID: 28399447
[TBL] [Abstract][Full Text] [Related]
29. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
[TBL] [Abstract][Full Text] [Related]
30. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
[TBL] [Abstract][Full Text] [Related]
31. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89.
von Schweinitz D; Hecker H; Harms D; Bode U; Weinel P; Bürger D; Erttmann R; Mildenberger H
J Pediatr Surg; 1995 Jun; 30(6):845-52. PubMed ID: 7545228
[TBL] [Abstract][Full Text] [Related]
32. Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma.
Wu JF; Chang HH; Lu MY; Jou ST; Chang KC; Ni YH; Chang MH
J Biomed Sci; 2017 Aug; 24(1):62. PubMed ID: 28851352
[TBL] [Abstract][Full Text] [Related]
33. An evaluation of the association between radiological parameters and survival outcomes in pediatric patients with hepatoblastoma.
Sirichamratsakul K; Kritsaneepaiboon S; Sripornsawan P; Kanjanapradit K; Laochareonsuk W; Sangkhathat S
Pediatr Surg Int; 2022 Nov; 38(11):1591-1600. PubMed ID: 36097077
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA expression might predict prognosis of epithelial hepatoblastoma.
Gyugos M; Lendvai G; Kenessey I; Schlachter K; Halász J; Nagy P; Garami M; Jakab Z; Schaff Z; Kiss A
Virchows Arch; 2014 Apr; 464(4):419-27. PubMed ID: 24570391
[TBL] [Abstract][Full Text] [Related]
35. Vascular invasion is a prognostic indicator in hepatoblastoma.
Shi Y; Commander SJ; Masand PM; Heczey A; Goss JA; Vasudevan SA
J Pediatr Surg; 2017 Jun; 52(6):956-961. PubMed ID: 28347528
[TBL] [Abstract][Full Text] [Related]
36. Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15.5 in hepatoblastoma.
Albrecht S; Hartmann W; Houshdaran F; Koch A; Gärtner B; Prawitt D; Zabel BU; Russo P; Von Schweinitz D; Pietsch T
Int J Cancer; 2004 Sep; 111(4):627-32. PubMed ID: 15239143
[TBL] [Abstract][Full Text] [Related]
37. Hepatoblastoma: glutamine depletion hinders cell viability in the embryonal subtype but high GLUL expression is associated with better overall survival.
Schmidt A; Armento A; Bussolati O; Chiu M; Ellerkamp V; Scharpf MO; Sander P; Schmid E; Warmann SW; Fuchs J
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3169-3181. PubMed ID: 34235580
[TBL] [Abstract][Full Text] [Related]
38. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.
Sumazin P; Peters TL; Sarabia SF; Kim HR; Urbicain M; Hollingsworth EF; Alvarez KR; Perez CR; Pozza A; Najaf Panah MJ; Epps JL; Scorsone K; Zorman B; Katzenstein H; O'Neill AF; Meyers R; Tiao G; Geller J; Ranganathan S; Rangaswami AA; Woodfield SE; Goss JA; Vasudevan SA; Heczey A; Roy A; Fisher KE; Alaggio R; Patel KR; Finegold MJ; López-Terrada DH
J Hepatol; 2022 Oct; 77(4):1026-1037. PubMed ID: 35577029
[TBL] [Abstract][Full Text] [Related]
39. The Role of N
Auld FM; Sergi CM; Leng R; Shen F
Cells; 2022 Apr; 11(9):. PubMed ID: 35563821
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and prognosis of patients with hepatoblastoma.
Jung SE; Kim KH; Kim MY; Kim DY; Lee SC; Park KW; Kim WK
World J Surg; 2001 Feb; 25(2):126-30. PubMed ID: 11338010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
